Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection.

HIV-1 LGMDD2 chemokines inflammation pathway transcriptome

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2022
Historique:
received: 20 12 2021
accepted: 05 04 2022
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 2 6 2022
Statut: epublish

Résumé

LGMDD2 is a rare form of muscular dystrophy characterized by one of the three heterozygous deletions described within the

Identifiants

pubmed: 35646913
doi: 10.3389/fcell.2022.839813
pii: 839813
pmc: PMC9136291
doi:

Types de publication

Journal Article

Langues

eng

Pagination

839813

Informations de copyright

Copyright © 2022 Diez-Fuertes, López-Huertas, García-Pérez, Calonge, Bermejo, Mateos, Martí, Muelas, Vílchez, Coiras, Alcamí and Rodríguez-Mora.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Neuropathology. 2013 Jun;33(3):276-80
pubmed: 23279333
Int J Mol Sci. 2020 Jun 22;21(12):
pubmed: 32580419
Biochem J. 2000 May 15;348 Pt 1:189-99
pubmed: 10794731
Prog Mol Biol Transl Sci. 2017;147:1-73
pubmed: 28413025
Virology. 1995 Feb 1;206(2):935-44
pubmed: 7531918
J Virol. 2010 Jan;84(1):397-406
pubmed: 19846519
Hum Genet. 2013 Aug;132(8):885-98
pubmed: 23568615
Brain. 2013 May;136(Pt 5):1508-17
pubmed: 23543484
J Leukoc Biol. 2007 Dec;82(6):1375-81
pubmed: 17709402
Nature. 2013 Nov 21;503(7476):402-405
pubmed: 24196705
Am J Hum Genet. 2012 May 4;90(5):925-33
pubmed: 22541558
Protein J. 2021 Aug;40(4):466-488
pubmed: 34110586
J Exp Clin Cancer Res. 2021 Mar 1;40(1):85
pubmed: 33648552
PLoS One. 2013 May 07;8(5):e63536
pubmed: 23667635
Cell Rep. 2012 Jun 28;1(6):753-63
pubmed: 22813749
Sci Rep. 2020 Jun 9;10(1):9265
pubmed: 32518229
J Virol. 1995 Nov;69(11):6705-11
pubmed: 7474080
PLoS Pathog. 2009 May;5(5):e1000437
pubmed: 19478882
Curr Drug Targets. 2003 Jul;4(5):409-29
pubmed: 12816349
J Biol Chem. 2012 Oct 5;287(41):34044-58
pubmed: 22872640
Front Immunol. 2014 Sep 25;5:461
pubmed: 25309543
Cell Host Microbe. 2008 Nov 13;4(5):495-504
pubmed: 18976975
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W316-22
pubmed: 21715386
Nucleic Acids Res. 2013 Jan;41(Database issue):D132-41
pubmed: 23118483
PLoS Pathog. 2019 Aug 29;15(8):e1007958
pubmed: 31465518
Mol Cell Biol. 2011 Jul;31(14):2854-66
pubmed: 21576360
Nat Immunol. 2010 May;11(5):373-84
pubmed: 20404851
Nat Immunol. 2017 May 18;18(6):612-621
pubmed: 28518156
Acta Neuropathol Commun. 2018 Dec 19;6(1):141
pubmed: 30567601
EMBO Mol Med. 2017 May;9(5):622-637
pubmed: 28264935
Science. 2008 Feb 15;319(5865):921-6
pubmed: 18187620
Nucleic Acids Res. 2019 May 21;47(9):4663-4683
pubmed: 30916345
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Nat Commun. 2018 Aug 24;9(1):3431
pubmed: 30143619
J Immunol. 2011 Nov 1;187(9):4389-91
pubmed: 22013204
PLoS One. 2011;6(7):e21800
pubmed: 21789182
J Biol Chem. 2017 Jun 9;292(23):9699-9710
pubmed: 28356354
Neuromuscul Disord. 2011 Aug;21(8):569-78
pubmed: 21724396
Nucleic Acids Res. 2018 Jan 4;46(D1):D58-D63
pubmed: 29106599
J Mol Biol. 2016 May 22;428(10 Pt A):2060-90
pubmed: 26523678
Front Immunol. 2021 Mar 11;12:634832
pubmed: 33777023
Retrovirology. 2013 Feb 15;10:20
pubmed: 23414560
Pract Neurol. 2009 Dec;9(6):314-23
pubmed: 19923111
J Cell Biol. 1999 Jun 14;145(6):1145-52
pubmed: 10366588
Nature. 2020 Jul;583(7815):310-313
pubmed: 32494006
Neurology. 2001 Feb 27;56(4):450-4
pubmed: 11222786
Curr Opin Virol. 2014 Feb;4:32-6
pubmed: 24525292
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2728-33
pubmed: 24449914
Cell. 2008 Oct 3;135(1):49-60
pubmed: 18854154
Neurol Genet. 2019 May 02;5(3):e337
pubmed: 31192305
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10154-9
pubmed: 11517331
J Pathol. 2018 Mar;244(3):311-322
pubmed: 29210073
Adv Pharmacol. 2018;81:241-330
pubmed: 29310800
Eur J Med Genet. 2019 Jul;62(7):103662
pubmed: 31071488
Neuropathol Appl Neurobiol. 2021 Feb;47(2):283-296
pubmed: 32896923
J Neurol. 2013 Aug;260(8):2033-41
pubmed: 23632945
Retrovirology. 2013 Apr 26;10:46
pubmed: 23622145

Auteurs

Francisco Diez-Fuertes (F)

AIDS Immunopathogenesis Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

María Rosa López-Huertas (MR)

AIDS Immunopathogenesis Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Javier García-Pérez (J)

AIDS Immunopathogenesis Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Esther Calonge (E)

AIDS Immunopathogenesis Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Mercedes Bermejo (M)

AIDS Immunopathogenesis Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Elena Mateos (E)

AIDS Immunopathogenesis Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Pilar Martí (P)

Neuromuscular Diseases Unit, Neurology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, Spain.

Nuria Muelas (N)

Neuromuscular Diseases Unit, Neurology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, Spain.

Juan Jesús Vílchez (JJ)

Neuromuscular Diseases Unit, Neurology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, Spain.

Mayte Coiras (M)

AIDS Immunopathogenesis Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

José Alcamí (J)

AIDS Immunopathogenesis Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
Infectious Diseases Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Sara Rodríguez-Mora (S)

AIDS Immunopathogenesis Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Classifications MeSH